Day One Biopharmaceuticals (NASDAQ: DAWN) has successfully completed its acquisition of Mersana Therapeutics (NASDAQ: MRSN) for $25 per share in cash plus contingent value rights worth up to $30.25 per share. The acquisition adds Emi-Le, a novel antibody-drug conjugate targeting B7-H4 for treating adenoid cystic carcinoma, to Day One's clinical p...

Law firm Brodsky & Smith announced investigations into four merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and provide fair value to shareholders. The investigations involve Alexander & Baldwin (acquisition by MW Group and Blackstone affiliates for $21.20/share), Udemy (acquisi...

Law firm Halper Sadeh LLC is investigating potential securities law violations and breaches of fiduciary duties for three companies involving mergers and acquisitions.

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies involved in recent merger and acquisition transactions.

Law firm Monteverde & Associates is investigating potential merger deals for four companies, examining whether shareholders are receiving fair compensation in recent acquisition transactions.